 |
 |
 |
FDA
Home Page | Search FDA Site |
FDA A-Z Index | Contact Dockets
Documents and comments received by the Division of Dockets Management may be posted
on the Internet. Please do not include personal
identifying information, i.e. date of birth, social security number, medical
information, etc., in your correspondence.
Submit Electronic Comments
Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.
Docket No. 2007N-0262, CDER 200612. Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine). Pages 53711-53733 [FR Doc. 07-4663 ] [TXT] [PDF] [PRE-PUB] Comments due November 19, 2007
Finding of No Significant Impact
Environmental Assessment
Docket No. 2007N-0229, OC 2007220. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices: Current Good Manufacturing Practice Quality System Regulations. Pages 53774-53778 [FR Doc. E7-18582 ] [TXT] [PDF] [PRE-PUB]
CDER 200773. Educational Workshops on Current Good Manufacturing Practices; Public Workshops. Pages 53778-53779 [FR Doc. E7-18556] [TXT] [PDF] [PRE-PUB]
Table of Contents for Entire Federal Register
Thursday, September 20, 2007
(TXT)
(PDF)